Top Qs
Timeline
Chat
Perspective
MiHKAL
Swiss pharmaceutical company From Wikipedia, the free encyclopedia
Remove ads
MiHKAL GmbH, with MiHKAL being an acronym of Molecules I Have Known and Loved, is a Swiss pharmaceutical company that is developing psychedelics and entactogens as potential medicines.[1][2] Matthias Grill is the founder and chief executive officer (CEO) of the company, while Tamara Hell is its co-founder and chief financial officer (CFO).[1][2] The name of the company is a play on the name of psychedelic chemist Alexander Shulgin's books PiHKAL (Phenethylamines I Have Known and Loved) and TiHKAL (Tryptamines I Have Known and Loved).[1][2]
MiHKAL has filed and published patents on prodrugs of psychedelics and/or entactogens.[2][3][4][5] In September 2021, Compass Pathways acquired MiHKAL's intellectual property (IP) and entered a non-exclusive partnership with the company to develop novel psychedelic compounds.[1][2][3][6][7][8] MiHKAL's drugs include lys-MDA and lys-MDMA, among others.[9][10][4][5]
The company MiHKAL should not be confused with the deceased psychedelic music artist of the name MiHKAL (standing for Music I Have Known and Loved; real name Michael Anderson).[11][12][13]
Remove ads
See also
References
External links
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads